# Amber Rathor

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/amber-rathor/

## Facts

| Field | Value |
| --- | --- |
| Citations | 27 |
| Field | Lung Cancer Treatments and Mutations |
| h-index | 3 |
| i10-index | 1 |
| Last Known Institution | All India Institute of Medical Sciences |
| OpenAlex ID | https://openalex.org/A5066313057 |
| ORCID iD | 0009-0000-7394-1838 |
| Works | 8 |

## Researcher papers

- [Mapping the immune landscape in small cell lung cancer by analysing expression of immuno-modulators in tissue biopsies and paired blood samples](https://scholariq.org/papers/mapping-the-immune-landscape-in-small-cell-lung-cancer-by-analysing-expression/)
- [Pleural effusion supernatant: a reliable resource for cell-free DNA in molecular testing of lung cancer](https://scholariq.org/papers/pleural-effusion-supernatant-a-reliable-resource-for-cell-free-dna-in-molecular/)
- [‘Plasma first’ approach for detecting epidermal growth factor receptor mutation in advanced non-small cell lung carcinoma](https://scholariq.org/papers/plasma-first-approach-for-detecting-epidermal-growth-factor-receptor-mutation-in/)
- [From bench to bedside and beyond: Challenges in direct KRAS targeting](https://scholariq.org/papers/from-bench-to-bedside-and-beyond-challenges-in-direct-kras-targeting/)
- [Baseline retinoblastoma transcriptional corepressor 1 (Rb1) functional inactivation is a pre-requisite but not sufficient for small-cell histological transformation in epidermal growth factor receptor (EGFR) mutant lung adenocarcinomas post-tyrosine kinase inhibitor therapy](https://scholariq.org/papers/baseline-retinoblastoma-transcriptional-corepressor-1-rb1-functional/)
- [Primary <i>de novo</i> Epidermal Growth Factor Receptor Mutant Small Cell Lung Carcinomas: Clinicopathological Study of a Rare Entity Presenting in Treatment-Naïve Setting with Review of Literature](https://scholariq.org/papers/primary-i-de-novo-i-epidermal-growth-factor-receptor-mutant-small-cell-lung/)
- [1713 Comprehensive Analysis of Genomic Landscapes in Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Carcinoma: Insights into Mechanisms of Tyrosine Kinase Inhibitor Resistance and Patterns of Disease Progression](https://scholariq.org/papers/1713-comprehensive-analysis-of-genomic-landscapes-in-epidermal-growth-factor/)
- [1698 Evaluating Nucleic Acid Integrity in Archived Lung Cancer Tissues: Implications for Biobanking in Translational Research](https://scholariq.org/papers/1698-evaluating-nucleic-acid-integrity-in-archived-lung-cancer-tissues/)

## Researcher topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Neuroendocrine Tumor Research Advances](https://scholariq.org/topics/neuroendocrine-tumor-research-advances/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Researcher university

- [All India Institute of Medical Sciences](https://scholariq.org/institutions/all-india-institute-of-medical-sciences/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.